ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 461,96
-0,39%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Labopharm Inc. (MM) (DDSS)

  7. Labopharm Inc. (MM) (DDSS) Actualités

DDSS

Labopharm Inc. (MM) (DDSS)

Labopharm Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:DDSS
DateHeureSourceTitreSymboleSociété
28/07/201113h00PR Newswire (Canada)Labopharm to host conference call Thursday, August 4, 2011 at 8:30 A.M. (ET)NASDAQ:DDSSLabopharm Inc. (MM)
24/06/201112h04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:DDSSLabopharm Inc. (MM)
23/06/201123h30PR Newswire (Canada)LABOPHARM ANNOUNCES REDUCTION OF ANGELINI LABOPHARM'S OLEPTRO™ SALES FORCENASDAQ:DDSSLabopharm Inc. (MM)
21/06/201123h04PR Newswire (US)LABOPHARM ANNOUNCES INTENTION TO DELIST FROM NASDAQNASDAQ:DDSSLabopharm Inc. (MM)
04/05/201113h00PR Newswire (US)LABOPHARM REPORTS FINANCIAL RESULTS FOR FIRST QUARTER 2011NASDAQ:DDSSLabopharm Inc. (MM)
29/04/201118h00PR Newswire (US)LABOPHARM TO HOST CONFERENCE CALL WEDNESDAY, MAY 4, 2011 AT 8:30 A.M. (ET)NASDAQ:DDSSLabopharm Inc. (MM)
29/04/201113h00PR Newswire (US)LABOPHARM PROVIDES UPDATE ON STRATEGIC REVIEW PROCESSNASDAQ:DDSSLabopharm Inc. (MM)
01/04/201123h00PR Newswire (US)LABOPHARM RECEIVES NOTICE FROM NASDAQ REGARDING MINIMUM MARKET VALUE OF LISTED SECURITIESNASDAQ:DDSSLabopharm Inc. (MM)
31/03/201123h13Edgar (US Regulatory)Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:DDSSLabopharm Inc. (MM)
22/03/201114h00PR Newswire (Canada)LABOPHARM ANNOUNCES WORKFORCE REDUCTION AND APPOINTMENT OF NEW CFONASDAQ:DDSSLabopharm Inc. (MM)
14/03/201112h00PR Newswire (US)LABOPHARM ANNOUNCES APPOINTMENT OF NEW PRESIDENT & CEONASDAQ:DDSSLabopharm Inc. (MM)
24/02/201113h00PR Newswire (US)LABOPHARM REPORTS PROGRESS AND FINANCIAL RESULTS FOR FOURTH QUARTER 2010NASDAQ:DDSSLabopharm Inc. (MM)
10/02/201116h40PR Newswire (US)LABOPHARM TO HOST CONFERENCE CALL THURSDAY, FEBRUARY 24, 2011 AT 8:30 A.M. (ET)NASDAQ:DDSSLabopharm Inc. (MM)
25/01/201114h00PR Newswire (US)LABOPHARM ANNOUNCES EXECUTIVE APPOINTMENTSNASDAQ:DDSSLabopharm Inc. (MM)
20/01/201115h46PR Newswire (Canada)LABOPHARM RECEIVES HEALTH CANADA APPROVAL FOR OLEPTRO(TM): A NEW ONCE-DAILY ANTIDEPRESSANT FOR THE TREATMENT OF MAJOR DEPRESSIVENASDAQ:DDSSLabopharm Inc. (MM)
07/01/201122h32Edgar (US Regulatory)Amended Report of Foreign Issuer (6-K/A)NASDAQ:DDSSLabopharm Inc. (MM)
03/01/201113h00PR Newswire (Canada)LABOPHARM MONETIZES ROYALTY STREAM FROM PURDUE FOR RYZOLT(TM)NASDAQ:DDSSLabopharm Inc. (MM)
31/12/201022h30PR Newswire (US)LABOPHARM RECEIVES NOTICE FROM NASDAQ REGARDING MINIMUM BID PRICE REQUIREMENTNASDAQ:DDSSLabopharm Inc. (MM)
12/11/201013h20PR Newswire (Canada)LABOPHARM RECEIVES NOTICE OF ANDA SUBMISSION WITH PARAGRAPH IV CERTIFICATION FOR GENERIC OF OLEPTRO™NASDAQ:DDSSLabopharm Inc. (MM)
11/11/201013h23PR Newswire (US)LABOPHARM REPORTS RESULTS FOR THIRD QUARTER 2010NASDAQ:DDSSLabopharm Inc. (MM)
28/10/201013h00PR Newswire (Canada)LABOPHARM TO HOST CONFERENCE CALL THURSDAY, November 11, 2010 AT 8:30 A.M. (ET)NASDAQ:DDSSLabopharm Inc. (MM)
14/10/201013h00PR Newswire (US)LABOPHARM AND PALADIN ANNOUNCE EXPANSION OF COMMERCIAL RELATIONSHIPNASDAQ:DDSSLabopharm Inc. (MM)
13/10/201015h42PR Newswire (Canada)LABOPHARM'S TWICE-DAILY TRAMADOL-ACETAMINOPHEN APPROVED IN EUROPENASDAQ:DDSSLabopharm Inc. (MM)
12/08/201013h00PR Newswire (US)Labopharm Reports Results for Second Quarter 2010NASDAQ:DDSSLabopharm Inc. (MM)
10/08/201015h00PR Newswire (US)Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adultsNASDAQ:DDSSLabopharm Inc. (MM)
06/08/201017h00PR Newswire (US)Labopharm to present at Canaccord Genuity 30th Annual Growth ConferenceNASDAQ:DDSSLabopharm Inc. (MM)
29/07/201013h00PR Newswire (US)Labopharm to host conference call Thursday, August 12, 2010 at 8:30 A.M.(ET)NASDAQ:DDSSLabopharm Inc. (MM)
09/07/201013h00PR Newswire (US)Labopharm Announces Amendment to Debt Facility Agreement with HerculesNASDAQ:DDSSLabopharm Inc. (MM)
04/06/201013h45PR Newswire (US)Labopharm comments on judgment in Purdue appeal of decision relating to patentsNASDAQ:DDSSLabopharm Inc. (MM)
20/05/201022h02PR Newswire (US)Labopharm announces completion of joint venture with AngeliniNASDAQ:DDSSLabopharm Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:DDSS

Dernières Valeurs Consultées

EU
EN
Bouygues
NASDAQ
AMZN
Amazon.com
EU
AF
Air FranceKLM
NYSE
KO
Coca Cola
SPI
SP500
S&P 500
NYSE
NKE
Nike
NYSE
JPM
JP Morgan Chase
EU
MC
Lvmh Moet Hennessy Louis...
COIN
ETHUSD
Ethereum
NYSE
DIS
Walt Disney
NASDAQ
NVDA
NVIDIA
NYSE
MCD
McDonalds
EU
HO
Thales
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés